QV Investors Inc. Decreases Position in National Research Co. (NASDAQ:NRC)

QV Investors Inc. lowered its position in shares of National Research Co. (NASDAQ:NRC - Free Report) by 12.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 395,102 shares of the company's stock after selling 56,048 shares during the period. National Research accounts for approximately 1.4% of QV Investors Inc.'s portfolio, making the stock its 25th largest position. QV Investors Inc. owned 1.61% of National Research worth $15,630,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. iA Global Asset Management Inc. purchased a new stake in National Research in the third quarter valued at $11,124,000. Charles Schwab Investment Management Inc. lifted its position in National Research by 4.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 111,434 shares of the company's stock valued at $4,944,000 after purchasing an additional 4,895 shares during the last quarter. Swiss National Bank lifted its position in National Research by 1.6% in the 3rd quarter. Swiss National Bank now owns 32,500 shares of the company's stock valued at $1,442,000 after purchasing an additional 500 shares during the last quarter. Comerica Bank bought a new stake in National Research in the 3rd quarter valued at about $6,939,000. Finally, Conestoga Capital Advisors LLC lifted its position in National Research by 6.0% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 773,215 shares of the company's stock valued at $34,308,000 after purchasing an additional 43,475 shares during the last quarter. Institutional investors and hedge funds own 47.26% of the company's stock.

National Research Trading Down 0.2 %

Shares of National Research stock traded down $0.09 during trading on Friday, hitting $37.00. The stock had a trading volume of 31,862 shares, compared to its average volume of 53,518. The stock has a 50 day simple moving average of $39.28 and a 200 day simple moving average of $40.80. The company has a market capitalization of $882.45 million, a PE ratio of 29.60 and a beta of 0.42. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.60. National Research Co. has a 1 year low of $36.08 and a 1 year high of $47.25.

National Research (NASDAQ:NRC - Get Free Report) last released its earnings results on Tuesday, February 13th. The company reported $0.36 earnings per share for the quarter. National Research had a net margin of 20.84% and a return on equity of 47.79%. The business had revenue of $38.00 million for the quarter.

National Research Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, April 15th. Investors of record on Friday, March 29th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 1.30%. The ex-dividend date of this dividend is Wednesday, March 27th. National Research's payout ratio is presently 38.40%.

Analyst Upgrades and Downgrades

Separately, TheStreet downgraded shares of National Research from a "b-" rating to a "c+" rating in a research report on Thursday, January 11th.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.